Park, Jieun
Chang, Eun Sol
Kim, Ji-Yeon
Chelakkot, Chaithanya
Sung, Minjung
Song, Ji-Young
Jung, Kyungsoo
Lee, Ji Hye
Choi, Jun Young
Kim, Na Young
Lee, Hyegyeong
Kang, Mi-Ran
Kwon, Mi Jeong
Shin, Young Kee
Park, Yeon Hee
Choi, Yoon-La
Funding for this research was provided by:
Ministry of Health & Welfare, South Korea (HI19C0141, HI19C0141, HI19C0141, HI19C0141, HI19C0141)
Ministry of Science and ICT, South Korea (2022R1A2C2006322, 2022R1A2C2006322, 2022R1A2C2006322, 2022R1A2C2006322, 2022R1A2C2006322, 2022R1A2C2006322)
Samsung Medical Center (#SMO1230021)
Article History
Received: 30 May 2023
Accepted: 9 January 2024
First Online: 18 January 2024
Declarations
:
: The study protocol was approved by the Institutional Review Board (IRB) of the SMC (IRB No. 2019-08-119) and was conducted per the Declaration of Helsinki. Written informed consent was obtained from all the patients.
: Not applicable.
: Jieun Park and Young Kee Shin received consulting fees from ABION, Inc. Na Young Kim and Young Kee Shin currently hold stocks at ABION, Inc. Mi-Ran Kang currently holds stocks at Gencurix Inc. The other authors declare no potential conflicts of interest relevant to this study.